Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy

Journal of Clinical Oncology

Volumn 17, Issue 5, 1999, Pages 1508-1515

  Wagner, Jeffrey D ^a   Schauwecker, Donald ^a   Davidson, Darrell ^a   Coleman III, John J ^a   Saxman, Scott ^a   Hutchins, Gary ^a   Love, Charlene ^a   Hayes, John T ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; GLUCOSE METABOLISM; HISTOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0032898502     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.5.1508     Document Type: Article

References (33)

1. Friedman RJ, Rigel DS, Silverman MK, et al: Malignant melanoma in the 1990s. CA Cancer J Clin 41:201-206, 1991
2. Boring CC, Squires TS, Tong T, et al: Cancer statistics, 1994. CA Cancer J Clin 44:7-26, 1994
3. MacLennan R, Green AC, McLeod GR, et al: Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84:1427-1431, 1992
4. Scotto J, Pitcher H, Lee JA: Indications of future decreasing trends in skin melanoma mortality among whites in the United States. Int J Cancer 49:490-497, 1991
5. Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:1902-1908, 1970
6. Balch CM, Murad TM, Soong SJ, et al: A multifactorial analysis of melanoma II: Prognostic factors in patients with stage I (localized) melanoma. Surgery 86:343-351, 1979
7. Balch CM, Murad TM, Soong SJ, et al: Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 43:883-888, 1979
8. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 177:392-399, 1992
9. Uren RF, Howman-Giles RB, Shaw HM, et al: Lymphoscintigraphy in high-risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 34:1435-1440, 1993
10. Pijpers R, Collet GJ, Meijer S, et al: The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 22:1238-1241, 1995
11. Reintgen D, Cruse CW, Wells K, et al: The orderly progression of melanoma nodal metastases. Ann Surg 220:759-767, 1994
12. Gershenwald JE, Mansfield PF, Lee JE, et al: Prognostic significance of the sentinel node (SLN) in stage I or II melanoma patients. Melanoma Res 7:S105, 1997 (suppl 1)
13. MacKie RM, Byrne D, Lyngam MK, et al: Prognostic evaluation of sentinel node biopsy. Melanoma Res 7:S102, 1997 (suppl 1) (abstr)
14. Horgan K, Hughes LE: Staging of melanoma. Clin Radiol 48:297-300, 1993
15. Buzaid AC, Sandler AB, Mani S, et al: Role of computed tomography in the staging of malignant melanoma. J Clin Oncol 11:638-643, 1993
16. Boni R, Huch-Boni R, Steinert H, et al: Antimelanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma. Dermatology 191:119-123, 1995
17. Kagan R, Witt T, Bines S, et al: Gallium-67 scanning for malignant melanoma. Cancer 61:272-274, 1988
18. Divigi CR, Larson SM: Radiolabeled monoclonal antibodies in the diagnosis and treatment of malignant melanoma. Semin Nucl Med 19:252-261, 1989
19. Gritters LS, Francis IR, Zasadny KR, et al: Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 34:1420-1427, 1993
20. Boni R, Boni RA, Steinert H, et al: Staging of metastatic melanoma by whole body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose. Br J Dermatol 132:556-562, 1995
21. Wagner JD, Schau wecker D, Hutchins G, et al: Initial assessment of positron emission tomography for detection of subclinical regional lymphatic metastases in melanoma. J Surg Oncol 64:181-189, 1997
22. Steinert HC, Boni RA, Buck A, et al: Malignant melanoma: Staging with whole body positron emission tomography and 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiology 195:705-709, 1995
23. Rinne D, Baum RP, Hor G, et al: Primary staging and followup of high risk melanoma patients with whole body 18 F-fluorodeoxyglucose positron emission tomography: Results of a prospective study of 100 patients. Cancer 82:1664-1671, 1998
24. Kirgan D, Guenther J, Bhattathiry M, et al: The importance of whole body PET scans on the management of metastatic malignant melanoma. Proc Am Soc Clin Oncol 13:396a, 1994 (abstr 1349)
25. Blessing C, Feine U, Geiger L, et al: Positron emission tomography and ultrasonography: A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma. Arch Dermatol 131:1394-1398, 1995
26. Damian DL, Fulham MJ, Thompson E, et al: Positron emission tomography in the detection and management of metastatic melanoma. Melanoma Res 6:325-329, 1996
27. Macfarlane DJ, Sondak V, Johnson T, et al: Prospective evaluation of 2-(18F)-2-deoxyglucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma. J Clin Oncol 16:1770-1776, 1998
28. Yao WJ, Hoh CK, Glaspy F, et al: Whole body FDG-PET imaging for staging of malignant melanoma: Is it cost effective? J Nucl Med 35:8P, 1994 (abstr 20)
29. Fleming ID, Cooper JS, Henson DE, et al (eds): AJCC Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott-Raven, 1997, pp 163-170
30. Ardizzoni A, Grimaldi A, Repeto L, et al: Stage I-II melanoma: The value of metastatic work-up. Oncology 44:87-89, 1987
31. Khansur T, Sanders J, Das S: Evaluation of staging workup in malignant melanoma. Arch Surg 124:847-849, 1989
32. Kuvshinoff BW, Kurtz C, Coit DG: Computed tomography in evaluation of patients with stage III melanoma. Ann Surg Oncol 4:252-258, 1997
33. Wagner JD, Davidson D, Coleman JJ III, et al: Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol (in press)